Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-011637
Filing Date
2025-05-20
Accepted
2025-05-20 12:57:58
Documents
52
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 586694
2 EX-31.1 ex31-1.htm EX-31.1 12965
3 EX-31.2 ex31-2.htm EX-31.2 13130
4 EX-32.1 ex32-1.htm EX-32.1 5739
5 EX-32.2 ex32-2.htm EX-32.2 5599
  Complete submission text file 0001641172-25-011637.txt   3925150

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE blnc-20250331.xsd EX-101.SCH 27589
7 XBRL CALCULATION FILE blnc-20250331_cal.xml EX-101.CAL 34389
8 XBRL DEFINITION FILE blnc-20250331_def.xml EX-101.DEF 146067
9 XBRL LABEL FILE blnc-20250331_lab.xml EX-101.LAB 231724
10 XBRL PRESENTATION FILE blnc-20250331_pre.xml EX-101.PRE 205584
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 642984
Mailing Address 407 LINCOLN ROAD SUITE 701 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD 4TH FLOOR MIAMI FL 33139 (305) 907-7600
Balance Labs, Inc. (Filer) CIK: 0001632121 (see all company filings)

EIN.: 471146785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-202959 | Film No.: 25967517
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)